Calcium nke Atorvastatin

Nkọwa dị mkpirikpi:

Aha API Ngosipụta Nkọwapụta US DMF EU DMF CEP
Calcium nke Atorvastatin Hypercholesterolemia N'ime ụlọ/CEP 29057 CEP 2015-034


Nkọwa ngwaahịa

Mkpado ngwaahịa

Nkọwa ngwaahịa

ndabere

Calcium Atorvastatin bụ ihe na-egbochi HMG-CoA reductase yana uru IC50 nke 150 nM.
HMG-CoA reductase bụ isi enzyme nke ụzọ mevalonate nke na-emepụta cholesterol.HMG-CoA bụ enzyme na-ebelata ọnụego yana ọ dị mkpa maka ibelata ọkwa cholesterol ọbara.HMG-CoA reductase dị na endoplasmic reticulum ma nwee ngalaba transmembrane asatọ.Ndị na-egbochi HMG-CoA reductase nwere ike ime ka ndị na-anabata LDL (lipoprotein dị ala) dị na imeju.Ọ na-eduga n'ịbawanye ọkwa catabolism nke plasma LDL ma belata mkpokọta cholesterol plasma nke bụ ihe dị mkpa na-ekpebi atherosclerosis.HMG-CoA reductase na-arụ ọrụ dị mkpa na njikọ cholesterol.HMG-CoA bụ naanị ebumnuche maka ọgwụ na-ebelata cholesterol.HMG-CoA reductase bụkwa enzyme dị mkpa maka mmepe.Ọrụ nke HMG-CoA reductase nwere njikọ na ntụpọ mbugharị sel germ.Mgbochi nke ọrụ ya nwere ike ibute ọbara ọgbụgba intracerebral[1].
Atorvastatin bụ ihe mgbochi HMG-CoA reductase nwere uru IC50 nke 154 nM.Ọ dị irè n'ịgwọ ụfọdụ dyslipidemias na hypercholesterolemia[1].Ọgwụ Atorvastatin na 40 mg na-ebelata mkpokọta cholesterol 40% mgbe ụbọchị 40 gachara.A na-ejikwa ya na-agwọ ndị ọrịa akwara ọbara ma ọ bụ ọrịa strok nwere ọkwa cholesterol nkịtị.[2].Atorvastatin na-ebelata apheresis lipoproteins dị ala n'ime ndị ọrịa site na ime ka ndị na-anabata LDL.
A na-emegharị ya na ọtụtụ metabolites nke dị mkpa maka mmetụta nke omume ọgwụgwọ site na CYP3A4 (cytochrome P450 3A4).[3].
Ntụaka:
[1].van Dam M, Zwart M, de Beer F, Smelt AH, Prins MH, Trip MD, Havekes LM, Lansberg PJ, Kastelein JJ: ịdị ogologo oge na nchekwa nke atorvastatin na ọgwụgwọ ụdị III siri ike yana dyslipidemia jikọtara ọnụ.Obi 2002, 88 (3): 234-238 .
[2].Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R. -nkezi mkpokọta cholesterol, na Anglo-Scandinavian Cardiac Excomes Trial--Lipid Lowering Arm (ASCOT-LLA): nnwale a na-achịkwa nke ọtụtụ etiti.Lancet 2003, 361 (9364): 1149-1158.
[3].Lennernas H: ọgwụ pharmacokinetics nke atorvastatin.Clin Pharmacokinet 2003, 42 (13): 1141-1160.

Ọdịdị chemical

Atorvastatin-Calcium

Asambodo

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

njikwa mma

Quality management1

Atụmatụ18Ọrụ nlebanya na-agbanwe agbanwe nke akwadoro4, na6A na-akwado ọrụ ngo.

Quality management2

Usoro njikwa ogo mba ụwa dị elu etinyela ntọala siri ike maka ire ahịa.

Quality management3

Nlekọta dị mma na-aga n'ihu na usoro ndụ nke ngwaahịa ahụ niile iji hụ na ịdịmma na mmetụta ọgwụgwọ.

Quality management4

Ndị otu Regulatory Affairs ndị ọkachamara na-akwado ịdịmma chọrọ n'oge ngwa na ndebanye aha.

njikwa mmepụta

cpf5
cpf6

Ahịrị nkwakọ ngwaahịa Korea Countec

cpf7
cpf8

Taiwan CVC ahịrị nkwakọ ngwaahịa

cpf9
cpf10

Line CAM Board Ịtali

cpf11

Igwe na-akpakọrịta Fette German

cpf12

Ihe nchọpụta mbadamba ihe ngosi nke Japan

cpf14-1

Ụlọ njikwa DCS

Onye mmekọ

Mmekọrịta mba ụwa
International cooperation
Imekọ ihe ọnụ n'ụlọ
Domestic cooperation

  • Nke gara aga:
  • Osote:

  • Dee ozi gị ebe a ziga anyị ya

    Ụdị ngwaahịa